NEW YORK, Nov 14 - Several months after announcing the establishment of a $100 million war chest to fight for a foothold in the genomics sector, IBM has embarked on its latest effort to win new business.

Big Blue is now conducting extensive market surveys and customer focus groups to try to figure out how to muscle their way into the already crowded bioinformatics and genomics market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.